1-3 of 3
Kate Ryan
Close
Sort by
Journal Articles

Routine Management, Healthcare Resource Use and Patient/Caregiver-Reported Outcomes of Patients with Transfusion-Dependent β-Thalassaemia in the United Kingdom: A Mixed Methods Observational Study

Farrukh Shah, MDMBBS,FRCPath, Paul Telfer, DM, FRCP, Mark Velangi, Shivan Pancham, Robert Wynn, Sally Pollard, Elizabeth Chalmers, Jonathan Kell, MD, Joe Hickey, PhD, Clark Paramore, MPH, Minesh Jobanputra, MD, Kate Ryan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3550.
https://doi.org/10.1182/blood-2019-129930
Published: 2019
Journal Articles

A Phase I, Multi-Dose, Dose Escalation Study of SGN-40 (anti-huCD40 mAb) in Patients with Refractory or Recurrent Multiple Myeloma.

Mohamad A. Hussein, MD, Ruben Niesvizky, MD, Nikhil Munshi, MD, James C. Berenson, MD, Kenneth C. Anderson, MD, Kate Ryan, BA, Karen Baumgartner, BA, Dennis M. Miller, PhD, Michael McDonald, MD
Journal: Blood
Blood (2004) 104 (11): 2413.
https://doi.org/10.1182/blood.V104.11.2413.2413
Published: 2004
Journal Articles

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

Clinical Trials & Observations
Richard A. Nash, James D. Bowen, Peter A. McSweeney, Steven Z. Pavletic, Kenneth R. Maravilla, Man-soo Park, Jan Storek, Keith M. Sullivan, Jinan Al-Omaishi, John R. Corboy, John DiPersio, George E. Georges, Theodore A. Gooley, Leona A. Holmberg, C. Fred LeMaistre, Kate Ryan, Harry Openshaw, Julie Sunderhaus, Rainer Storb, Joseph Zunt, George H. Kraft
Journal: Blood
Blood (2003) 102 (7): 2364–2372.
https://doi.org/10.1182/blood-2002-12-3908
Published: 2003